Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Vet Parasitol ; 141(1-2): 18-29, 2006 Oct 10.
Article in English | MEDLINE | ID: mdl-16806713

ABSTRACT

This observational study of 100 dogs naturally infected with Babesia canis rossi determined whether severity of parasitaemia was associated with outcome of infection and documented the relative distribution of parasitised red blood cells (pRBC) in capillary and venous circulation. The association between increased parasitaemias and outcome with a clinically compromised circulation was also investigated. Outcome was defined as either hospitalisation with death, or hospitalisation with eventual recovery or treatment as an outpatient. Dogs were enrolled if large babesias were found on stained thin capillary blood smears made from an ear prick. Thin venous smears were prepared from jugular or cephalic blood. Parasitaemias were manually counted and expressed as the percent pRBC. Ten dogs died, 50 recovered after hospitalisation and 40 were treated as outpatients. Venous sampling site did not affect venous parasitaemia (P=0.6). Both capillary and venous parasitaemias of dogs that died were significantly higher than those of dogs that recovered after hospitalisation (P=0.002) and dogs that were treated as outpatients (P<0.0001). When assessing the whole group, capillary parasitaemia (median 0.61%, range <0.05-71.6%, interquartile range (IQR) 0.22-3.75%) was significantly higher than venous parasitaemia (median 0.14%, range 0-30.6%, IQR 0.046-0.52%) with P<0.0001. The 21 dogs with a clinically compromised circulation were more likely to die (P<0.0001) and had significantly higher capillary (median 5.98%, range 0.09-71.6%, IQR 2.44-19.41%) and venous (median 2.81%, range <0.05-30.6%, IQR 0.17-9.03%) parasitaemias than the 79 dogs with a clinically normal circulation (capillary median parasitaemia 0.38%, range <0.05-12.87%, IQR 0.16-1.42%; venous median parasitaemia 0.096%, range 0-6.13%, IQR <0.05-0.33%; P<0.0001). This study shows that high parasitaemia is significantly associated with death in B c rossi infected dogs. The previous clinical suspicion that capillary parasitaemias are usually higher than venous parasitaemias is confirmed. Thus capillary samples are the most appropriate diagnostic samples. Prior observations that a clinically compromised circulation is associated with death are confirmed. Despite the highly significant association between compromised circulation and higher parasitaemia, it is thought unlikely that parasite burden is the sole trigger for circulatory collapse.


Subject(s)
Antiprotozoal Agents/therapeutic use , Babesia/pathogenicity , Babesiosis/veterinary , Dog Diseases/blood , Erythrocytes/parasitology , Animals , Babesiosis/blood , Babesiosis/drug therapy , Babesiosis/mortality , Confidence Intervals , Dog Diseases/drug therapy , Dog Diseases/mortality , Dogs , Odds Ratio , Parasitemia/mortality , Parasitemia/veterinary , Severity of Illness Index , Treatment Outcome
2.
J S Afr Vet Assoc ; 86(1): 1187, 2015 Apr 21.
Article in English | MEDLINE | ID: mdl-26018737

ABSTRACT

Granulomatosis with polyangiitis (Wegener's granulomatosis) is one of the idiopathicimmune-mediated small-vessel vasculitides described in humans which are characterised by the presence of circulating antineutrophil cytoplasmic antibodies. It most commonly involves capillaries, venules and arterioles of the ear, nose and throat, lungs and glomeruli. A case of destructive haemopurulent rhinitis associated with relapsing periods of pyrexia, lethargy and stiffness as well as generalised pulmonary infiltrates in a young Anatolian shepherd dog is presented that closely resembles granulomatosis with polyangiitis (GPA) as reported in humans. Perinuclear antineutrophil cytoplasmic antibodies (pANCA) were detected in the dog's serum. Signs resolved promptly and completely once immunosuppressive doses of prednisone were administered, and have not recurred. This is the first report onthe use of pANCA to investigate rhinitis in dogs. It is also, to the authors' knowledge, the first description of a relapsing haemopurulent lytic rhinitis in this species. The concurrent manifestations of erosive haemopurulent rhinitis, ground-glass opacities on pulmonary computed tomography, pyrexia and listlessness resemble GPA as described in humans.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Dog Diseases/drug therapy , Granulomatosis with Polyangiitis/veterinary , Prednisone/therapeutic use , Rhinitis/veterinary , Animals , Anti-Inflammatory Agents/administration & dosage , Antibodies, Antineutrophil Cytoplasmic/blood , Diagnosis, Differential , Dog Diseases/etiology , Dogs , Female , Granulomatosis with Polyangiitis/drug therapy , Granulomatosis with Polyangiitis/etiology , Prednisone/administration & dosage , Rhinitis/drug therapy , Rhinitis/etiology
3.
J S Afr Vet Assoc ; 85(1): 1042, 2014 May 13.
Article in English | MEDLINE | ID: mdl-24830757

ABSTRACT

L-2 hydroxyglutaric aciduria is an autosomal recessive error of metabolism that manifests as an encephalopathy. The most common presenting signs are seizures, tremors, ataxia and/ or dementia. Some affected dogs show only subtle behavioural changes. Amongst canines, the condition has been best described in Staffordshire Bull Terriers. Although this is the first reported case in South Africa, at least three other affected dogs have been indentified by polmerase chain reaction (PCR) in this country. Affected dogs have normal haematology, serum biochemistry and routine urine analysis. This report discusses the advantages and limitations of the three main diagnostic modalities, namely: magnetic resonance imaging, urine gas chromatography-mass spectrometry and genetic testing. The aim of this report is to increase awareness of the condition, assist diagnosis in encephalopathic dogs and improve detection of carriers amongst breeding stock.


Subject(s)
Brain Diseases, Metabolic, Inborn/veterinary , Dog Diseases/diagnosis , Animals , Anticonvulsants/therapeutic use , Brain Diseases, Metabolic, Inborn/diagnosis , Brain Diseases, Metabolic, Inborn/drug therapy , Dog Diseases/drug therapy , Dog Diseases/urine , Dogs , Female , Phenobarbital/therapeutic use , Riboflavin/therapeutic use , South Africa , Vitamin B Complex/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL